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Abstract
Background: Cutaneous leishmaniasis (CL) is a vector-borne parasitic disease characterized by the presence of one or more
lesions on the skin that usually heal spontaneously after a few months. Most cases of CL worldwide occur in Southwest Asia,
Africa and South America, and a number of cases have been reported among troops deployed to Afghanistan. No vaccines
are available against this disease, and its treatment relies on chemotherapy. The aim of this study was to characterize
parasites isolated from Canadian soldiers at the molecular level and to determine their susceptibility profile against a panel
of antileishmanials to identify appropriate therapies.
Methodology/Principal Findings: Parasites were isolated from skin lesions and characterized as Leishmania tropica based
on their pulsed field gel electrophoresis profiles and pteridine reductase 1 (PTR1) sequences. Unusually high allelic
polymorphisms were observed at several genetic loci for the L. tropica isolates that were characterized. The drug
susceptibility profile of intracellular amastigote parasites was determined using an established macrophage assay. All
isolates were sensitive to miltefosine, amphotericin B, sodium stibogluconate (Pentostam) and paromomycin, but were not
susceptible to fluconazole. Variable levels of susceptibility were observed for the antimalarial agent atovaquone/proguanil
(Malarone). Three Canadian soldiers from this study were successfully treated with miltefosine.
Conclusions/Significance: This study shows high heterogeneity between the two L. tropica allelic versions of a gene but
despite this, L. tropica isolated from Afghanistan are susceptible to several of the antileishmanial drugs available.
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Introduction
Cutaneous leishmaniasis (CL) is a vector-borne parasitic disease
characterized by one or more sores or nodules on the skin that often
heal spontaneously after a few months, resulting in scar formation. This
disease has been frequently diagnosed in military personnel who were
returning from duty in Southwest Asia [1,2], with several outbreaks
observed in troops deployed to Iraq [3] and Afghanistan [2,4].
Currently, Kabul is believed to be the largest focus of CL worldwide,
having an estimated incidence of 67,500 new cases per annum [5].
Whereas CL in Iraq has been mostly caused by Leishmania major,C Li n
Afghanistan can either be due to Leishmania tropica or Leishmania major
[6], and differences in clinical features have been observed between the
two species. Notably, L. tropica tends to cause more chronic infections
and may rarely progress to a systemic form of the disease termed
viscerotropic leishmaniasis, a situation requiring special attention [7].
There is a lack of consensus about the best therapeutic options
for the treatment of CL, mainly due to the lack of properly
controlled clinical trials [8]. Because of the self-healing nature of
the illness, the treatment of CL depends on several factors such as
the site and number of lesions, the aetiology of the disease, and
personal preferences. One of the main therapeutic options that has
been used for the treatment of CL for many years relied on the
local or systemic administration of pentavalent antimony [9].
Because Leishmania species are susceptible to heat, the local
application of radio frequency to generate heat at the site of the
lesions was also shown to yield cure rates equivalent to systemic
pentavalent antimony [10,11]. Nonetheless, the availability of
effective oral treatments would constitute attractive therapeutic
options against CL, and there is evidence of benefit for the use of
oral triazoles like itraconazole and fluconazole against L. tropica
and L. major, respectively [8]. Miltefosine, another orally
www.plosntds.org 1 January 2012 | Volume 6 | Issue 1 | e1463administered drug, was shown to be an effective treatment against
visceral leishmaniasis in India [12] and cutaneous leishmaniasis in
South America [13], but there is only limited data about its
efficacy against CL in Southwest Asia [14–16].
In this report, we describe the molecular characterization and in
vitro drug susceptibility profiles of Leishmania parasites isolated from
four Canadian soldiers suffering from CL after returning from
Afghanistan. Primary treatment based on oral fluconazole failed to
improve the appearance of lesions in three of them. We show that
L. tropica was responsible for the lesions in every patient and that
the parasites are highly heterogeneous but nonetheless remained
sensitive to most known antileishmanials.
Methods
Ethics Statement
The skin biopsies were taken after appropriate informed consent
was obtained, and as part of the routine patient care. Leishmania
parasite isolates were submitted for susceptibility testing in order to
assist in the clinical management of individuals with suboptimal
response to fluconazole. No additional samples or procedures were
done.
Parasites and culture
Fresh tissue samples obtained through biopsy of the skin lesions
were collected from three Canadian soldiers who returned from
duty in southern Afghanistan with suspected CL lesions at the
Department of Medical Microbiology and Infectious Diseases of the
University of Manitoba in Winnipeg. Samples were submitted to
culture,pathological examination,and PCRanalyses.Thehistology
revealed the presence of granulotomatous inflammation. The
isolates identified as 017102, 431462, and 072218 underwent
routine clinical laboratory studies at the National Reference Center
for Parasitology in Montreal, QC. An additional skin lesion sample
(identified as 18693) was collected from a Canadian soldier also
returning from Afghanistan and suspected of suffering from CL at
the CHUQ in Quebec, QC. Parasites were isolated from the biopsy
in SDM-79 medium supplemented with 20% heat-inactivated fetal
calf serum, 5 mg/ml hemin and 10 mM biopterin at pH 7.0 and
25uC. The molecular characterization of parasites was done at the
Centre de Recherche en Infectiologie du Centre de Recherche du
CHUL, Quebec, QC. The L. tropica strains 175 and 482, isolated
from Iranian patients [17], and L. tropica MHOM/SU/74/K27,
obtained from the ATCC, were used as reference isolates.
Pulsed field gel electrophoresis karyotyping
Agarose blocks containing Leishmania cells were prepared as
described [18]. Briefly, cells were resuspended in HEPES buffer at a
density of 5610
8 cells/ml and mixed with low-melting-point
agarose. Cells were lysed in the presence of 0.5 M EDTA
(pH 9.5), 1% SLS, and proteinase K (500 mg/ml). Their chromo-
somes were electrophoresed by a BioRad (Hercules, California,
United States) contour-clamped homogeneous electric field (CHEF)
mapper for separating 0.1–1.0 Mbp DNAs over a period of 27 h.
Chromosomes were visualized after ethidium bromide staining.
Sequence analysis
Species identification and heterogeneity were studied by
sequencing the pteridine reductase 1 (PTR1), glucose-6-phosphate
isomerase (GPI), nucleoside hydrolase 1 (NH1), dihydrofolate
reductase-thymidylate synthase (DHFR-TS), stearic acid desaturase
(SAD), mannose phosphate isomerase (MPI), aspartate amino-
transferase (ASAT), 6-phosphogluconate dehydrogenase (PGD),
glucose-6-phosphate dehydrogenase (G6PDH) and cytochrome B
(CYTB) genes. Genomic DNA was extracted from mid-log phase
parasites using the DNAzol reagent (Invitrogen) as described by
the manufacturer. PCR reactions were performed in 50 ml using
the primers listed in Table S1 and contained 100 ng of total
gDNA, 50 pmol of each primer, 0.2 mM of dNTPs, 1.5 mM of
MgCl2 and 5 U of Taq polymerase. Amplification was performed
in 30 cycles, each cycle using the following conditions: denatur-
ation at 94uC for 1 min, annealing at 58uC for 1 min and
extension at 72uC for 1–2 min (depending on the size of PCR
products). A final extension was performed at 72uC for 5 min.
PCR products were migrated on agarose gel, purified with the
QIAquick Gel Extraction Kit (Qiagen) and sequenced with an
ABI Prism 3100 DNA sequencer. The PTR1 sequences obtained
were compared to those of eight Leishmania reference isolates using
the Lasergene Software (DNASTAR, Inc.).
Phylogenetic analysis
Multiple sequence alignments were performed on the amino
acid sequence of the PTR1 coding region using ClustalW [19] with
the default settings. The resulting multiple alignments were
subjected to phylogenetic analysis using the neighbor-joining
method [20] with the Poisson correction distance method as
implemented in the MEGA3.1 software [21]. The reliabilities of
each branch point were assessed by the analysis of 1000 bootstrap
replicates.
Viability test
The 50% inhibitory concentrations (IC50) of drugs on
macrophages were established by using the 3-(4,5-dimethylthia-
zol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Briefly,
THP-1 cells were differentiated in 96-well flat-bottom microtiter
plates in a volume of 100 ml of complete RPMI 1640 medium
supplemented with 10% heat-inactivated fetal calf serum and
20 ng/ml phorbol myristate acetate. Plates were incubated at
37uC in the presence of 5% CO2 for 3 days. Drugs were added at
1/10 of the final concentration in a volume of 10 ml in duplicate.
After 96 h of incubation, 10 ml of MTT (10 mg/ml) was added to
each well and plates were further incubated for 4 h. The
enzymatic reaction was stopped by the addition of 100 mlo f
50% ethanol-10% sodium dodecyl sulfate. The plates were
Author Summary
Cutaneous leishmaniasis (CL) is a vector-borne parasitic
disease transmitted by the bite of sandflies, resulting in
sores on the skin. No vaccines are available, and treatment
relies on chemotherapy. CL has been frequently diagnosed
in military personnel deployed to Afghanistan and
returning from duty. The parasites isolated from Canadian
soldiers were characterized by pulsed field gels and by
sequencing conserved genes and were identified as
Leishmania tropica. In contrast to other Leishmania species,
high allelic polymorphisms were observed at several
genetic loci for the L. tropica isolates that were character-
ized. In vitro susceptibility testing in macrophages showed
that all isolates, despite their genetic heterogeneity, were
sensitive to most antileishmanial drugs (antimonials,
miltefosine, amphotericin B, paromomycin) but were
insensitive to fluconazole. This study suggests a number
of therapeutic regimens for treating cutaneous leishman-
iasis caused by L. tropica among patients and soldiers
returning from Afghanistan. Canadian soldiers from this
study were successfully treated with miltefosine.
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temperature before reading the optical density at 570 nm with a
96-well scanner. The viability assays were performed in duplicates.
As a control, the cytotoxicity of reagents used to solubilize the
drugs was determined and no substantial toxicity was found.
Drug susceptibility assays
L. tropica promastigote parasites were transfected with the firefly
luciferase-containing vector pSP1.2 LUC aHYGa as previously
described [22]. THP-1 cells were differentiated by incubation at
37uC in the presence of 5% CO2 for 3 days in complete RPMI
1640 medium supplemented with 10% heat-inactivated fetal calf
serum and 20 ng/ml phorbol myristate acetate. The cells were
washed with pre-warmed medium and subsequently infected with
L. tropica promastigotes at a parasite/macrophage ratio of 15:1 for
3 h. Non-internalized parasites were removed by several washes.
Luciferase activity was measured after 4 days of exposure to
fluconazole, Pentostam, amphotericin B, miltefosine, paromomy-
cin or Malarone as described elsewhere [23].
Results
Molecular characterization of Leishmania isolates
Parasites recovered from biopsy samples of four Canadian
military personnel who returned from deployment in Kandahar,
Afghanistan, with clinical manifestations of CL were characterized
by pulsed field gel electrophoresis (PFGE). PFGE conditions
optimized for the analysis of larger chromosomes did not show any
major differences in the chromosome numbers and sizes between
our isolates (Fig. 1A) and revealed that they were genetically
closely related to the ATCC L. tropica strain MHOM/SU/74/K27
and to a L. tropica isolate recovered from a patient suffering from
CL in Iran (L. tropica 175) [17,24]. The analysis of smaller
chromosomes revealed considerable karyotype differences, how-
ever (Fig. 1B).
Figure 1. Karyotypes of Afghan and Iranian Leishmania tropica isolates as characterized by PFGE. Cells were embedded and lyzed in
agarose and their chromosomes were electrophoresed and stained with ethidium bromide. A. 600–1300 kb electrophoresis B. 100–500 kb
electrophoresis. The field isolates 017102, 431462, 072218 and 18693 from Afghanistan have closely related karyotype to the L. tropica reference
strains 175 and MHOM/SU/74/K27. M, yeast chromosomes molecular weight marker (BioRad).
doi:10.1371/journal.pntd.0001463.g001
Figure 2. Phylogenetic analysis of the PTR1 sequences. Amino
acid sequences were aligned using the ClustalW algorithm. The
resulting multiple alignment was subjected to phylogenetic analysis
by using the neighbor-joining method with Poisson correction as
implemented in the MEGA3.1 software. The field isolates 017102,
431462, 072218, and 18693 from Afghanistan are clustering with the L.
tropica reference strains 175 and MHOM/SU/74/K27. The reliabilities of
each branch point were assessed by the analysis of 1000 bootstrap
replicates.
doi:10.1371/journal.pntd.0001463.g002
Leishmania tropica from Afghanistan
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pteridine reductase 1 (PTR1) sequence [17]. PCR fragments of the
coding region of PTR1 were amplified from genomic DNA extracted
from the clinical isolates and sequenced. The sequences generated
were compared to thoseofeight Leishmaniareferencestrainsandwere
shown to be closely related to L. tropica sequences (data not shown). A
neighbor-joining phylogenetic analysis generated from the translated
PTR1 sequences further confirmed that the four CL strains derived
from Canadian soldiers were L. tropica parasites (Fig. 2).
Leishmania tropica genetic heterozygosity
The PTR1 nucleotide sequences of the four L. tropica isolated from
Canadian soldiers revealed the presence of single nucleotide
polymorphisms (SNPs) at five different positions (Table 1). The
changes in nucleotide were conservative (Table 1), and the same
polymorphisms were also observed in two other strains of L. tropica
(strains 482 and MHOM/SU/74/K27) that we have analyzed
(Table 2). The heterozygous gene sequences were detected as split
peaksinthechromatogramgeneratedbythesequencingofthePTR1
locus in both directions, using DNA extracted from populations of
parasites. This type of polymorphism was not observed when
sequencing the PTR1 gene of L. infantum and L. major (Table 2). To
assess whether these polymorphisms corresponded to population
heterogeneity or to parasite heterozygocity, the PTR1 sequence of
cloned parasites from three distinct L. tropica strains (MHOM/SU/
74/K27, 072218 and 482) was determined (3 clones for each strain).
Again, the same PTR1 polymorphisms were detected in every clone
tested. Each allele was detected at a frequency of 50%, which
suggests that parasiteswereharbouring two distinctalleles. The same
two alleles were detected in every L. tropica strain studied (Table 1),
which is reflected by the homogenous clustering of the L. tropica
isolates in the neighbour-joining phylogenetic analysis (Fig. 2).
To assess the extent of the genetic polymorphism in our panel of
L. tropica strains, nine additional genes located on distinct
chromosomes, i.e. glucose-6-phosphate isomerase (GPI), nucleo-
side hydrolase 1 (NH1), dihydrofolate reductase-thymidylate
synthase (DHFR-TS), stearic acid desaturase (SAD), mannose
phosphate isomerase (MPI), aspartate aminotransferase (ASAT),
6-phosphogluconate dehydrogenase (PGD), glucose-6-phosphate
dehydrogenase (G6PDH), and cytochrome B (CYTB), were also
sequenced in clones of strains 482, 072218 and MHOM/SU/74/
K27. Heterozygous sites were observed at every locus (Table 1)
except for MPI and CYTB (Table 2). In addition, the same alleles
were detected in every L. tropica strains studied, except for the
ASAT gene, which had three additional polymorphic sites common
Table 1. Polymorphisms in L. tropica isolates
a,b.
Genes
c Nucleotides
d Amino acids
PTR1 G 243 A Ala 81 Ala
G 561 T Pro 187 Pro
T 624 A Ala 208 Ala
A 642 G Pro 214 Pro
T 690 C Ala 230 Ala
NH1 T 243 A Ile 81 Ile
A 698 G His 233 Arg
C 752 G Pro 251 Arg
G 828 T Ala 276 Ala
DHFRTS A 911 G Gln 304 Arg
G 1095 A Gln 365 Gln
A 1149 G Leu 383 Leu
A 1469 C Glu 490 Ala
SAD C 189 T Ser 63 Ser
C 1251 T Gly 417 Gly
T 1335 A Asp 445 Glu
GPI G 109 T Ala 37 Ser
C 135 G Ala 45 Ala
G 230 A Ser 77 Asn
C 383 T Ala 128 Val
C 699 T Asn 233 Asn
C 888 T Val 296 Val
T 1290 C Ile 430 Ile
PGD G5 4C A l a1 8A l a
A 114 G Thr 38 Thr
G 249 T Thr 83 Thr
A 447 G Pro 149 Pro
A 489 G Ala 163 Ala
G 623 T Arg 208 Leu
G 666 T Glu 222 Asp
A 679 G Asn 227 Asp
G 876 C Met 292 Ile
A 884 G Tyr 295 Cys
G 903 C Ala 301 Ala
G 1056 C Leu 352 Leu
A 1228 G Asn 410 Lys
C1293 T Ala 431 Ala
G 1383 C Gly 461 Gly
ASAT A 55 C Lys 19 Gln
A 978 C Ala 326 Ala
C 1141 T Pro 381 Ser
G6PDH A 178 G Asn 60 Asp
A 198 A Glu 66 Glu
C 294 T Gly 98 Gly
A 463 G Asn 155 Asp
T 669 C Gly 223 Gly
A 1038 G Pro 346 Pro
A 1039 G Ile 347 Val
G 1083 C Ala 361 Ala
C 1191 T Gly 397 Gly
Genes
c Nucleotides
d Amino acids
A 1542 G Pro 514 Pro
aNucleotide polymorphisms and corresponding amino acid changes are shown.
bThe polymorphisms in bold cause an amino acid substitution.
cThe polymorphisms indicated were common to every L. tropica isolates
analyzed, except for PGD, G6PDH,a n dSAD, which were not polymorphic in L.
tropica MHOM/SU/74/K27.
dFor nucleotide numbering, +1 corresponds to the A of the ATG translation
initiation codon.
PTR1 – pteridine reductase 1; NH1 – nucleoside hydrolase 1; DHFRTS –
dihydrofolate reductase-thymidylate synthase; SAD – stearic acid desaturase;
GPI – glucose-6-phosphate isomerase; PGD – 6-phosphogluconate
dehydrogenase; ASAT – aspartate aminotransferase; G6PDH – glucose-6-
phosphate dehydrogenase.
doi:10.1371/journal.pntd.0001463.t001
Table 1. Cont.
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MHOM/SU/74/K27 (Table 2), and the PGD, G6PDH, and SAD
genes, which were not polymorphic in L. tropica MHOM/SU/74/
K27 (Table 2). In contrast to the PTR1 locus, however, the
polymorphisms observed at the NH1, DHFR-TS, SAD, PGD,
G6PDH, ASAT, and GPI loci were non-conservative for at least one
position, with some genes having several non-conservative
heterozygous sites (Table 1). These polymorphisms were not
observed in other species outside L. tropica (Table 2). To rule out
polymerase errors, the sequencing of at least three independent
PCR products was done for each particular nucleotide position, as
it would be quite rare that the presence of the same SNPs in
different PCR reaction comes from polymerase errors. Moreover,
for some genes (for example PTR1), PCR products were TA
cloned and independent clones were sequenced for the confirma-
tion of the SNPs using primers within the pGEM-T easy vector,
hence ruling out the possibility of polymerase errors.
Drug susceptibility profiles of L. tropica clinical isolates
Three of the four Canadian soldiers were initially treated with
oral fluconazole without any clinical improvements. To establish
whether the therapeutic failure was due to parasites unresponsive to
fluconazole and to test whether these parasites were sensitive to
classical antileishmanials, in vitro susceptibility testing was performed
with the four L. tropica isolates using the human monocyte cell line
THP-1 and recombinant parasites transfected with the firefly
luciferase gene. The latter system is a convenient and rapid
quantitative method to monitor the growth of intracellular parasites
[23]. Growth was compared between mock-treated parasites and
parasites exposed to fluconazole, Pentostam, amphotericin B,
miltefosine, and paromomycin. We observed that L. tropica
intracellular amastigotes were insensitive to fluconazole at concen-
trations that were achievable in vitro (Table 3). Fluconazole was
highly active when we tested it against C. albicans (results not shown).
In contrast, when compared to our L. tropica reference strain 175, all
L. tropicaisolatestestedweresensitive toamphotericin B,miltefosine,
Pentostam,andparomomycinasintracellularparasites(Table3and
Figure 3). The only exception was L. tropica 18693, for which a
slightly higher miltefosine EC50 was observed in comparison to the
other L. tropica strains (Table 3).
One soldier infected by CL had to travel to Central Africa and
was on Malarone anti-malaria prophylaxis. Intriguingly, his
Table 2. Single nucleotide polymorphisms within Leishmania species for 10 genes
a.
Gene GPI PTR1 NH1 PGD ASAT G6PDH DHFR-TS SAD MPI CYTB
Chromosome 12 23 29 35 24 34 6 14 32 *
L. major
Friedlin
0 00 000 0 0 0 0
L. infantum
JPCM5
0 00 000 0 0 0 0
L. infantum
LEM 3843
0 0 0N DN DN D N D N D N D N D
L. donovani infantum 0 0 0N DN DN D N D N D N D N D
L. tropica
MHOM/SU/74/K27
7 54 030 4 0 0 0
L. tropica
IRAN 482
75 4 1 5 6 1 0 4 3 00
L. tropica
072218
75 4 1 5 6 1 0 4 3 00
ND – not done.
aFor each gene, the number of heterozygous sites is indicated.
*The CYTB gene is located on kinetoplast DNA.
Abreviations: PTR1 – pteridine reductase 1; NH1 – nucleoside hydrolase 1; DHFR-TS – dihydrofolate reductase-thymidylate synthase; SAD – stearic acid desaturase; GPI –
glucose-6-phosphate isomerise; PGD – 6-phosphogluconate dehydrogenase; ASAT – aspartate aminotransferase; G6PDH – glucose-6-phosphate dehydrogenase; MPI –
mannose phosphate isomerise; CYTB – Cytochrome B.
doi:10.1371/journal.pntd.0001463.t002
Table 3. Susceptibility of L. tropica clinical isolates to antileishmanial drugs.
Strains EC50
a
AmphotericinB
(mg/ml)
Paromomycin
(mg/ml)
Miltefosine
(mg/ml)
Pentostam
(mg/ml)
Malarone
(mg/ml)
Fluconazole
(mg/ml)
175 0.5160.08 19.068.1 0.1960.07 300632 .8 .275
017102 0.5960.29 7.461.7 0.1160.004 188639 6.660.1 .275
431462 0.3260.18 3.260.9 0.0960.004 14264 3.660.6 .275
072218 0.5160.07 9.861.8 0.1560.07 142612 4.461.1 .275
18693 0.7260.33 5.864.8 0.6560.33 ND .8 .275
aDetermined as amastigotes in THP-1 cells.
doi:10.1371/journal.pntd.0001463.t003
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so we tested whether Malarone had any activity against L. tropica
isolates using the intracellular amastigote assay. The toxicity of
Malarone to the THP-1 cells was first established by MTT
viability assay, and this cell line was found to display a Malarone
IC50 of 32 ug/ml. No THP-1 cytotoxicity was observed for
Malarone concentrations up to 10 ug/ml. Using drug concentra-
tions below 10 ug/ml, we found that three L. tropica strains were
sensitive to Malarone as intracellular amastigotes (Table 3),
including the strain that was isolated from the patient whose CL
regressed during Malarone prophylaxis.
Discussion
We describe here the drug susceptibility and molecular
characterization of L. tropica isolates derived from Canadian
soldiers returning from Afghanistan. The isolates were identified
as L. tropica by phylogenetic studies based on the PTR1 sequence,
an approach proven to be useful for the molecular identification
of Leishmania species [17]. Moreover, the PFGE karyotypes of the
recovered Leishmania parasites were similar to those of L. tropica
reference strains. This is consistent with epidemiological data that
showed the majority of CL cases in Afghanistan being due to this
species [5,25]. Interestingly, the sequence of PTR1 revealed
several SNPs in distinct L. tropica isolates. This phenomenon
appeared to be widespread across the L. tropica genome, as it was
also observed at other genetic loci on different chromosomes.
Most of the loci analyzed code for proteins that are part of the
panel of enzymes used for the characterization of Leishmania
species by multilocus enzyme electrophoresis [26]. Among these,
six (GPI, NH1, ASAT, G6PDH, PGD,a n dMPI) were further
shown to be useful markers for the molecular characterization of
Leishmania strains and species [27–29]. CYTB was chosen as a
mitochondrial gene representative, since it has also been reported
to be phylogenetically informative [30,31]. The SAD and DHFR-
TS loci were randomly chosen. DNA sequencing of cloned
parasites revealed a number of heterozygous sites at these loci,
some of which led to non-conservative changes. Although the
prevailing mode of reproduction of Leishmania appears to be
clonal [32], heterozygosity at several sites within genes or at
distinct loci is suggestive of genetic exchange between strains
[27], and this phenomenon has previously been observed in other
Leishmania species [27,28,32–35]. Most of these studies used
microsatellite markers with high mutation rates as indicators of
heterozygocity, however, and this is the first report about
extensive heterozygocity within coding regions in L. tropica.
Nonetheless, the heterozygosity of the L. tropica isolates appears to
be fixed, the same alleles being found among strains for most of
the loci studied except for the reference L. tropica MHOM/SU/
74/K27. This is suggestive of clonal propagation within foci of
endemicity and is consistent with the anthroponotic mode of
transmission of L. tropica in urban and peri-urban environments of
Afghanistan [5]. L. tropica parasites were known to display genetic
heterogeneity at the population level [34–37] and to be
responsible for a spectrum of clinical manifestations including
cutaneous, chronic, or viscerotropic leishmaniasis [7]. Unfortu-
nately, the small number of isolates available for analysis
prevented correlating heterozygocity with clinical data or drug
susceptibility. However, this seems to be unique to L. tropica since
other species did not show this level of allelic polymorphism
(Table 2).
Although CL is generally self-limiting, the complexity of the
clinical spectrum associated with L. tropica infections emphasizes
the need for treatment. Evidence suggested that the disruption of
ergosterol biosynthesis by oral azoles is an effective treatment
against CL [38,39]. However, a species-specific effect was found to
be important to the clinical outcome conferred by azole molecules,
with itraconazole and fluconazole being more active against L.
tropica and L. major, respectively [8]. Here, the failure of oral
fluconazole to improve the appearance of cutaneous lesions was
indeed explained by the intrinsic resistance of our L. tropica isolates,
the amastigote parasites being insensitive to the highest flucona-
zole concentration achievable in vitro using an established
intracellular assay (Table 3). All isolates were sensitive to the
other drugs tested, however, with the exception of Malarone, for
which variable levels of susceptibility were observed. While
anecdotal, CL regressed in one soldier during Malarone
prophylaxis. Although we cannot exclude spontaneous healing, it
might be worthwhile to evaluate the usefulness of this drug against
CL in properly controlled experiments.
Miltefosine is an orally administered antileishmanial approved
for the treatment of visceral leishmaniasis in India [12], with
demonstrated efficacy against CL in some regions of South
America [13]. In contrast, mostly sporadic data have been
reported regarding the efficacy of miltefosine against CL in
Southwest Asia [14–16]. Based on the results of our drug
susceptibility screening, soldiers were treated with miltefosine
and healing of their CL lesions was observed [40]. The patient
Figure 3. Paromomycin susceptibility of Leishmania tropica field isolates recovered from soldiers suffering from CL. The four L. tropica
isolates from Afghanistan are sensitive to paromomycin as intracellular amastigotes. Intracellular parasites were incubated for 4 days with the
indicated concentrations of paromomycin. The mean of two independent experiments done in duplicate is shown. Values are represented as
numbers of relative light units (RLU).
doi:10.1371/journal.pntd.0001463.g003
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discontinue therapy due to abdominal pain and in the face of a
contracting lesion. The other soldiers tolerated medication well
and lesions resolved at follow up.
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